AC Immune (ACIU) Net Margin (2015 - 2026)
AC Immune (ACIU) posted quarterly Net Margin of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and up 99.99% quarter-over-quarter from 0.21% in Q4 2025.
AC Immune (ACIU) Net Margin (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Net Margin for 10 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.02% (down 2.0% YoY), while the FY2025 annual figure was 0.02%, down 2.0% from the prior year.
- Net Margin rose to 0.0% in Q1 2026 per ACIU's latest filing, from 0.21% in the prior quarter.
- Across five years, Net Margin topped out at 0.0% in Q3 2024 and bottomed at 2.43% in Q4 2022.
- Historically, Net Margin has averaged 0.27% across 4 years, with a median of 0.0% in 2025.
- On a YoY basis, Net Margin climbed as much as 0 bps in 2025 and fell as far as 16 bps in 2025.
- AC Immune's Net Margin stood at 2.43% in 2022, then soared by 98 bps to 0.04% in 2024, then sank by 362 bps to 0.21% in 2025, then surged by 100 bps to 0.0% in 2026.
- Business Quant data shows ACIU's Net Margin at 0.0% in Q1 2026, 0.21% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | -85.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.54% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -0.21% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2022 | -2.43% |
| Sep 30, 2022 | 0.00% |
| Dec 31, 2020 | -1,956.99% |
| Sep 30, 2020 | -1,564.92% |
| Jun 30, 2020 | -1,357.34% |
| Mar 31, 2020 | -51.97% |
| Dec 31, 2019 | -2,104.53% |
| Sep 30, 2019 | 855.59% |
| Jun 30, 2019 | -1,025.61% |
| Mar 31, 2019 | 80.87% |
| Dec 31, 2018 | -1,246.92% |